Cabio Biotech (Wuhan) Co., Ltd. Price (688089.SS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

169,211,417

(0.7211)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People's Republic of China. Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $12.04-30.12
  • Market Cap 4.49B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Mr. Dewei Yi
  • IPO Date: December, 19, 2019
  • Country: CN
  • Currency: CNY
  • Headquaters: No Data
  • Employees: 508

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation